The law firm Schalla national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pfizer Inc. (“Pfizer” or “the Company”). PFE for violations of securities laws.
The investigation focuses on whether the company made false and/or misleading statements and/or failed to disclose information relevant to investors. Pfizer is the subject of a report published by Bloomberg on October 26, 2022. According to the report, the company is under investigation by Italian officials who claim it hid at least €1.2 billion in profits through a money transfer scheme to avoid paying taxes in the country. The investigation reportedly began earlier in 2022 and will span from 2017 to 2019.
If you are a shareholder who has suffered a loss, Click here to participate.
We also encourage you to contact Brian Schall of Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067 at 424-303-1964 to discuss your rights free of charge. You can also contact us via the law firm’s website at www.schallfirm.comor by email at bschall@schallfirm.com.
In this case, the class has not yet been certified and you will not be represented by a lawyer until it is certified. If you don’t do anything, you can remain absent.
The law firm of Schall represents investors around the world and specializes in securities class actions and shareholder disputes.
This press release may be considered an attorney’s solicitation in some jurisdictions under applicable laws and ethics rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221026006167/en/
